Primidone

Golden State Medical Supply Inc. faces a nationwide Class III recall for 8,526 bottles of Primidone Tablets, 50 mg, due to Acemetacin API cross-contamination. This FDA-initiated action, impacting an anti-epileptic drug, underscores critical quality control vulnerabilities and necessitates immediate supply chain risk assessment for procurement and regulatory teams.

American Health Packaging has initiated a Class III recall of 225,000 Primidone Tablets, USP, 50 mg, distributed nationwide, due to trace Acemetacin API cross-contamination. This voluntary action, initiated May 1, 2026, impacts supply chain stability for an essential anti-epileptic, demanding immediate review by procurement and regulatory teams to mitigate disruption and ensure patient safety.